Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CLYR Health vs Found

By GLP-1 ScorecardUpdated

CLYR Health
Site position #298

Lower score

FoundFactor scores not reassessed.
Site position #7

Higher score

Score comparison

Found has the higher recorded score — 83.5/100 to 62.2/100.

Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

Before you choose

Before comparing the headline prices, the CLYR Health review and the Found review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, CLYR Health vs Layla and CoreAge Rx vs Found compare each of them with another graded program, and the list of alternatives to CLYR Health ranks the programs closest to CLYR Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueFound +39
39
78
Dose & formulationFound +6
88
94
Clinical oversightFound +12
74
86
Labs & monitoringFound +30
52
82
FulfillmentFound +7
77
84
Contract termsFound +33
37
70
CLYR Health · top barFound · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCLYR HealthFound
WeighScore62.2/10083.5/100
GradeCB
Site position#298#7
Semaglutide$169 per 28-day vial (starting dose, compounded; higher doses $199–229)$149 first, then $269 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)
Tirzepatide$149 first month (starting dose, compounded; continuing doses $249–329/month)$199 first, then $339 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)
CoverageCoverage not publishedU.S. service with state, treatment and insurance restrictions; confirm your eligibility
Brand-name accessYesYes
Oral / sublingualYesYes
CLYR Health

Site position #298 · C

Strengths

  • Publishes dose-specific single- and two-month purchase totals before intake
  • Medication packs include provider review, medication, syringes and shipping
  • Terms identify MD Integrations and The Pharmacy Hub as partners
  • Optional $99/month ongoing care is separate from one-time medication packs

What to consider

  • Tirzepatide starter pricing does not continue at higher doses; semaglutide vials cover 28 days
  • Product ineligibility refund promise conflicts with broad nonrefundable terms
  • Semaglutide page contains both cold-pack and room-temperature shipping descriptions
  • State eligibility and selected-order renewal terms require confirmation
Found

Site position #7 · B

Factor scores not reassessed.

Strengths

  • Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
  • Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
  • Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
  • Terms name possible independent medical groups and describe check-ins and messaging

What to consider

  • Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
  • Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
  • Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
  • Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
  • The assigned compounder, actual treating practice and individual license status remain unresolved
  • A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence

Featured provider

Found

Factor scores not reassessed.

Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard